Compare Conagra Brands Inc (CAG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Conagra Brands Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Conagra Brands Inc trades at $14.17 (market cap $6.86B), while State Street SPDR S&P Biotech ETF trades at $156.04. The key difference: Conagra Brands Inc pays a 9.77% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Conagra Brands Inc nearer its low. Which is the better fit depends on your goals.
| CAG | XBI | |
|---|---|---|
Market Cap | $6.86B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $20.02 | $164.28 |
52-Week Low | $12.58 | $85.16 |
Enterprise Value | $14.13B | — |
Dividend Yield | 9.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Conagra Brands Inc
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of revenue and profits). It has a significant presence in the freezer aisle, with brands such as Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Other popular brands include Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. While the majority of revenue is sold into the U.S. retail channel, 9% of fiscal 2022 sales were to the food-service channel, down from 11% in fiscal 2019 due to the pandemic.
Read more on CAG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
